Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New treatments for neuropsychiatric disorders claimed in recent patent literature

Nov. 17, 2005

New CETP inhibitors disclosed in recent Merck & Co. patent

Nov. 17, 2005

Recent patents describe novel anti-hepatitis agents

Nov. 17, 2005

Novel therapeutics for gastrointestinal disorders claimed in recent Altana patent

Nov. 16, 2005

Novel agents for HIV infection imparted in recent patent literature

Nov. 16, 2005

Novel agents for the treatment of neurological disorders disclosed in recent patents

Nov. 16, 2005

Agents for metabolic disorders prepared and tested

Nov. 15, 2005

Recent Bristol-Myers Squibb patent claims compounds with potential for thrombotic disorders

Nov. 15, 2005

Novel antiinfective agents disclosed in recent patent literature

Nov. 15, 2005

Recent patents cover novel agents for respiratory disorders

Nov. 14, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...